Specialty Pharmaceutical Company dedicated to patients living with chronic conditions

Filing date Description Form Filing Group Filer View

Statement of changes in beneficial ownership of securities

4
3,4,5
Broadfin Capital, LLC 0001103021-19-000008.pdf 0001103021-19-000008.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Greenleaf Peter 0001103021-19-000006.pdf 0001103021-19-000006.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Watson W. Mark 0001103021-19-000009.pdf 0001103021-19-000009.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Davis Todd C 0001103021-19-000007.pdf 0001103021-19-000007.rtf View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001193125-19-216837.pdf 0001193125-19-216837.rtf 0001193125-19-216837.xls View HTML

Quarterly report which provides a continuing view of a company's financial position

10-Q
Quarterly Filings
0001193125-19-216858.pdf 0001193125-19-216858.rtf 0001193125-19-216858.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
ODONNELL FRANCIS E JR 0001628280-19-009862.pdf 0001628280-19-009862.rtf View HTML

Post-effective amendment to an S-8 filing

S-8 POS
Registration Statements
0001193125-19-205463.pdf 0001193125-19-205463.rtf 0001193125-19-205463.xls View HTML

Post-effective amendment to an S-8 filing

S-8 POS
Registration Statements
0001193125-19-205457.pdf 0001193125-19-205457.rtf 0001193125-19-205457.xls View HTML

Post-effective amendment to an S-8 filing

S-8 POS
Registration Statements
0001193125-19-205467.pdf 0001193125-19-205467.rtf 0001193125-19-205467.xls View HTML

Copyright Morningstar

BioDelivery Sciences Acquires U.S. Commercial Rights to Symproic®
Thank you. We will get back to you soon